U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243132) titled 'Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)' on Nov. 17.
Brief Summary: The goal of this observational study is to identify and describe the clinical characteristics, health status, socio-economic impacts and quality of life of patients alive for three years after diagnosis of metastatic Lung cancer and no longer receiving cytotoxic chemotherapy. The main question is to identify the needs of these patients in terms of health status (impact of cancer treatments, incidence of new diseases, cardiovascular, diabetes, second cancers), socio-economic aspects, quality of lif...